Serial Number | 88136782 |
Word Mark | PROTRIEVE |
Filing Date | Friday, September 28, 2018 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, May 9, 2022 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, February 5, 2019 |
Goods and Services | Oral, transdermal, injectable and intravaginal contraceptive preparations, intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, Central Nervous System disease and disorders, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent for medical purposes; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, October 6, 2018 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Allergan Sales, LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Irvine, CA 92612 |
Party Name | Allergan Sales, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Madison, NJ 07940 |
Event Date | Event Description |
Monday, May 9, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, May 9, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
Friday, September 10, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, September 9, 2021 | SOU EXTENSION 5 GRANTED |
Thursday, September 2, 2021 | SOU EXTENSION 5 FILED |
Thursday, September 9, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Thursday, September 2, 2021 | SOU TEAS EXTENSION RECEIVED |
Tuesday, March 30, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, March 26, 2021 | SOU EXTENSION 4 GRANTED |
Friday, March 26, 2021 | SOU EXTENSION 4 FILED |
Friday, March 26, 2021 | SOU TEAS EXTENSION RECEIVED |
Saturday, September 19, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, September 17, 2020 | SOU EXTENSION 3 GRANTED |
Thursday, September 17, 2020 | SOU EXTENSION 3 FILED |
Thursday, September 17, 2020 | SOU TEAS EXTENSION RECEIVED |
Thursday, March 26, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, March 24, 2020 | SOU EXTENSION 2 GRANTED |
Tuesday, March 24, 2020 | SOU EXTENSION 2 FILED |
Tuesday, March 24, 2020 | SOU TEAS EXTENSION RECEIVED |
Thursday, September 26, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, September 24, 2019 | SOU EXTENSION 1 GRANTED |
Tuesday, September 24, 2019 | SOU EXTENSION 1 FILED |
Tuesday, September 24, 2019 | SOU TEAS EXTENSION RECEIVED |
Tuesday, April 2, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, February 5, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 5, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, January 16, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, December 28, 2018 | ASSIGNED TO LIE |
Friday, December 7, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 14, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, November 14, 2018 | NON-FINAL ACTION E-MAILED |
Wednesday, November 14, 2018 | NON-FINAL ACTION WRITTEN |
Tuesday, November 13, 2018 | ASSIGNED TO EXAMINER |
Saturday, October 6, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 2, 2018 | NEW APPLICATION ENTERED |